Shares in Optomed are currently priced at €8.4. At that level they are trading at 31.09% discount to the analyst consensus target price of 0.00. Analysts covering Optomed currently have a consensus Earnings Per Share (EPS) forecast of -0.17 for the next financial year.
2021-04-08
Nyhetssvepet onsdag 31 mars. 31 mars, 2021. De senaste artiklarna från BioStock » Lipum genomför emission för att komma in i klinisk fas » Ziccum tar Optomed, Blusense and Beactica winner of Nordics Stars 2018 Award From left: Alpo Keinänen, Design Director, Optomed; Filippo Bosco, CEO and founder, Blusense Diagnostics and Per Källblad, CEO Palstaraadille ruodittavaksi AEYE & Optomed yhteistyötä koskien. Optomed AYEY on ilmeisesti tulossa perusterveydenhoidon protokolliin, jahka FDA-lupa saadaan. Eilinen AEYE tiedote kuulostaa lupaavalta. Syksyn tiedote: Optomed and AEYE Health to introduce a handheld AI fundus camera 18.9.2020 https://bit.ly/3fsYcxP Eilinen tiedote:-- Optomed on vasta kasvu- ja laajennusvaiheessa, ja se aikoo osinkojen jakamisen sijaan keskittyä enemmän liiketoiminnan kehittämiseen. Tällä hetkellä Optomed osake kurssi on miinuksella.
Optomed Smartscope® PRO is the next generation hand-held medical camera that provides high image quality which fulfills international ISO 10940 fundus camera standard requirements. Four interchangeable modular optics make the camera even more versatile. The lightweight camera incorporates advanced technology in a portable design. The Optomed DRS (Dynamic Respiratory Scope) is the most advanced equine upper respiratory tract diagnostic tool designed to achieve an accurate diagnosis of upper airway pathologies. The DRS provides a safe e˚ective system for imaging the equine upper respiratory tract … Optomed Aurora hand-held fundus camera introduces a totally new concept in fundus imaging where high-quality imaging meets ease-of-use.
The Optomed DRS (Dynamic Respiratory Scope) is the most advanced equine upper respiratory tract diagnostic tool designed to achieve an accurate diagnosis of upper airway pathologies. The DRS provides a safe e˚ective system for imaging the equine upper respiratory tract …
Optomed ilmoitti marraskuussa 2019 suunnittelevansa listautumista Helsingin pörssiin. Optomed, Oulu, Finland. 1K likes · 113 talking about this.
The Optomed DRS (Dynamic Respiratory Scope) is the most advanced equine upper respiratory tract diagnostic tool designed to achieve an accurate diagnosis of upper airway pathologies. The DRS provides a safe e˚ective system for imaging the equine upper respiratory tract during real training conditions at speed.
Marije Ane Oman, specialistke oftalmologije. Očesni center Optomed tvorita dve med seboj prepleteni in usklajeni celoti: Optika Škofja Loka in ambulanta, ki med seboj sodelujeta pri zagotavljanju celostne oskrbe naših pacientov. Få detaljerad information om Optomed PLC (OPTOMED) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Optomed rapporter och mycket mer. Optomed är verksamma inom medicinteknik. Bolaget bedriver idag forskning och utveckling av specialiserade ögonkameror. Utveckling sker av både hård- och mjukvara som vidaresäljs under olika varumärken.
Yhtiön …
2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. Optomed Plc is a Finnish health care technology company and one of the leading providers of handheld fundus cameras and eye-screening solutions. Optomed combines cameras with software and AI to
2021-04-08
Optomed Oyj on suomalainen terveysteknologiayhtiö, joka kehittää ja kaupallistaa kädessä pidettäviä silmänpohjakameroita, joita voidaan käyttää erilaisten silmäsairauksien diagnosoimisessa ja seurannassa. Optomedilla on myös ohjelmistoliiketoimintaa.
Doblougska priset
The company combines handheld screening devices with software and artificial intelligence to redefine the diagnosis process for blinding eye diseases such as diabetic retinopathy. The Optomed DRS (Dynamic Respiratory Scope) is the most advanced equine upper respiratory tract diagnostic tool designed to achieve an accurate diagnosis of upper airway pathologies. The DRS provides a safe e˚ective system for imaging the equine upper respiratory tract during real training conditions at speed. TEL AVIV, Israel, Sept. 21, 2020 /PRNewswire/ -- AEYE Health and Optomed have agreed to enter clinical and commercial collaboration to introduce an AI fundus camera Aurora AEYE.
Optomed combines handheld fundus cameras with software and
Dietary suppliments created by or recommened by Dr. Sam Walters, WellSpring Clinic, Scottsdale, Arizona
Optomed is one of the leading companies in handheld fundus imaging. The company has focused on bringing the technology that is traditionally in big desktop fundus cameras into a small, compact, and portable camera. Due to their size, cost-effectiveness and mobility, handheld cameras can be taken into any healthcare center, or pharmacy, globally.
Parkering erik dahlbergsgymnasiet
nattknappen
kenshi wo mezashite nyuugaku shita no ni mahou tekisei 9999 nan desu kedo_
ken ring kungsbacka
sjuksköterska hemsjukvård stockholm
nyköping golfklubb
arla lediga jobb
Shares in Optomed are currently priced at €8.4. At that level they are trading at 31.09% discount to the analyst consensus target price of 0.00. Analysts covering Optomed currently have a consensus Earnings Per Share (EPS) forecast of -0.17 for the next financial year.
En 2009, grâce à une collaboration avec des vétérinaires de renom, nous avons conçu le DRS® une PREMIERE MONDIALE pour examiner les voies respiratoires du cheval durant l'effort. Optomed är verksamma inom medicinteknik. Bolaget bedriver idag forskning och utveckling av specialiserade ögonkameror. Utveckling sker av både hård- och mjukvara som vidaresäljs under olika varumärken.